Her research focus is the study of inherited diseases of skin and hair, and a major objective of her laboratory is to develop innovative therapies through an advanced molecular understanding of disease pathogenesis. Dr. Christiano has published extensively in the peer-reviewed literature, and her breakthrough work in EB can be found in journals including Science Translational Medicine, Nature Genetics, the Journal of Clinical Investigation, PNAS, and the Journal of Investigative Dermatology. She is on the board of trustees and scientific advisory board of DEBRA of America, and is the current President of the Society for Investigative Dermatology.
Epidermolysis bullosa is a family of rare skin blistering conditions that currently have no cure. EB can have devastating and even life-threatening sequelae, including the development of cutaneous squamous cell cancer associated with the most severe forms of dystrophic EB. Those that live with the condition can continually experience great discomfort and negative quality of life, as the current treatments are palliative in nature.
Read the full article: Download PDF
Advancing Innovation in Dermatology Inc. is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code. | Donations are tax-deductible as allowed by law.